Zymeworks
ZYME
212 hedge funds and large institutions have $1.88B invested in Zymeworks in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 71 increasing their positions, 62 reducing their positions, and 19 closing their positions.
158% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $5.9M
158% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 19
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
15% more funds holding
Funds holding: 184 → 212 (+28)
15% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 62
2.56% less ownership
Funds ownership: 98.05% → 95.49% (-2.6%)
11% less capital inflows, than outflows
Capital inflows: $256M | Capital outflows: $288M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Asset Management
Paris,
France
|
+$39.7M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$36.6M |
| 3 |
Perceptive Advisors
New York
|
+$25.5M |
| 4 |
Rubric Capital Management (New York)
New York
|
+$22.7M |
| 5 |
Capricorn Fund Managers
London,
United Kingdom
|
+$22.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Redmile Group
San Francisco,
California
|
-$70.1M |
| 2 |
Morgan Stanley
New York
|
-$30.4M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$30.3M |
| 4 |
Blackstone
New York
|
-$27.6M |
| 5 |
Tang Capital Management
San Diego,
California
|
-$23.2M |
ZYME Hedge Fund Activity: Q4 2025 in Review
212 of the 8,319 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2025, worth a combined $1.88B — up 49% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new ZYME positions and 19 closed out — a net gain of 30 holders — while 71 added to existing stakes and 62 trimmed.
The largest buyer was BNP Paribas Asset Management, opening a new position worth an estimated $39.7M. The largest seller was Redmile Group, cutting an estimated $70.1M.
- 212 institutional investors held Zymeworks (ZYME) as of Q4 2025, up from 184 in Q3 2025.
- Funds reported $1.88B of Zymeworks stock for Q4 2025, up 49% quarter-over-quarter.
- 49 funds opened new Zymeworks positions in Q4 2025 and 19 closed out, a net change of +30 holders.
- The largest Zymeworks buyer in Q4 2025 was BNP Paribas Asset Management, an estimated $39.7M added.
- The largest Zymeworks seller in Q4 2025 was Redmile Group, an estimated $70.1M sold.
Based on aggregated 13F filings for Q4 2025.